Familial breast cancer (update): guideline consultation

This updated guideline is in draft form for consultation. It includes a number of potential new recommendations on issues including; when to offer genetic testing; what surveillance strategies should and should not be offered; and the use of tamoxifen or raloxifene as treatments to prevent breast cancer. Registered stakeholders are invited to comment on the provisional recommendations until the 25th February 2013. Press release Consultation documents and further information
Source: Health Management Specialist Library - Category: UK Health Authors: Source Type: blogs